Search

Home > Research contracts > Authorisation to sign contracts
Research Contracts

Authorisation to sign contracts

The University Council delegates authority to conclude first, second, third and fourth level contracts to the following officers:

(a) the Vice-Chancellor;
(b) the Deputy Vice-Chancellor responsible for research;
(c) the Registrar;
(d) the Executive Director: Finance;
(e) the Director Research Contracts and Innovation (RC&I);
(f) Contracts Officers (defined as a manager in Research Contracts and Innovation (RC&I) designated in writing by the Registrar)
(g) the Dean/Deputy Dean or Director of Research of a Faculty or in CHED or in the GSB in which the research is to be conducted;
(h) the Director and the Deputy Director of the Graduate School of Business (where the research is to be conducted in the GSB)

First-level contracts

Simple contracts between UCT and one or more third parties where the:

  • value of the contracts is less than R228,000 including VAT; and
  • contract contains no restrictions on publication; and
  • Intellectual Property is owned by UCT.

A first level contract, which is not a Material Transfer Agreement, may be approved and signed on behalf of UCT by any of the officers listed in paragraph 3 above.
A first-level contract, which is a Material Transfer Agreement, may be approved and signed on behalf of UCT by any of the officers listed in (e) and (f) in paragraph 3 above, subject to the completion of the necessary due diligence documentation by the Principal Investigator.


Second-level contracts

Second-level contracts between UCT and one or more third parties:

  • where the value of the contract is less than R2,280,000 including VAT; and
  • which do not contain restriction on publication or contains only a standard provision for limited restriction on publications that have been approved by the Deputy Vice Chancellor responsible for research, and
  • which have been reviewed  by one of the officers listed above and do not contain any provisions considered by the reviewer to be unusual.

A second-level contract must be approved by at least two of those listed in paragraph 3 above, provided that at least one of the following is one of these authorities:
(a) the Vice-Chancellor;
(b) the Deputy Vice-Chancellor responsible for research;
(c) the Registrar;
(d) the Executive  Director: Finance;
(e) the Director: Research Contracts & Innovation;
(f) a Contracts Officer (defined as a manager in RC&I expressly authorised by the Registrar).


Third-level contracts

Third-level contracts Contracts between UCT and one or more third parties:

  • where the value of the contract is R2,280,000 or more including VAT; and/or
  • where there is a non-standard restriction on publication; or
  • where the contract contains an unusual provision which in the opinion of a contracts officer requires review at one level up; or
  • contains a provision which the reviewing contracts officer thinks is contrary to policy

A third-level contract may be approved by at least two of the officers listed in paragraph 3 above, provided that at least one of the following is one of these authorities:
(a) the Vice-Chancellor;
(b) the Deputy Vice-Chancellor responsible for research;
(c) the Registrar;
(d) the Executive Director: Finance; or
(e) the Director: Research Contracts & Innovation (RC&I)
(f) a Contracts Officer (defined as a manager in RC&I expressly authorised by the Registrar);

  • provided that where the value of the contract exceeds R11,400,000 including VAT, the contract must be approved by two of the officers listed in (a) to (e) of this paragraph.
  • provided that where the value of the contract exceeds R17,100,000 including VAT, the contract must be approved by two of the officers listed in (a) to (d) of this paragraph and signed by any of the officers listed in (a) to (e).

Fourth-level contract (clinical trials)

Contracts between UCT and one or more third parties to conduct clinical trials

  • where the value of the contract is less than or equal to R2,280,000 including VAT; and
  • which do not contain restrictions on publication, or contain only standard provisions for limited restrictions on publication that has been approved by the DVC Research or the VC, or
  • which contain publications restrictions which are considered standard for multi-center clinical trials notwithstanding the fact that such restriction would otherwise
  • be considered non-standard;and
  • which has been reviewed by one of the officers listed below and do not contain any provisions considered by the reviewer to be unusual.(Clinical trials are level four contracts except those which contain a provision which the reviewing officer thinks is contrary to policy or which are valued at over R2,280,000including VAT, in which case they are level three contracts.)

A level four contract must be approved by at least two of those listed in paragraph 3 above, provided that at least one of the following is one of these authorities:
(a) the Vice-Chancellor;
(b) the Deputy Vice Chancellor responsible for research
(c) the Registrar;
(d) the Executive Director: Finance;
(e) the Director Research Contracts and Innovation; or
(f) a Contracts Officer.

In approving a research contract the authorising officer must satisfy him or herself,and sign a statement, that the draft contract has ethical clearance, is appropriately priced and protects UCT's interests adequately. This statement will be filed with the UCT copy of the contract. The statement must be on the appropriate form

Once a contract has been approved by the officer(s) in terms of paragraphs 4 to 8 above, that officer, or one of the other authorising officers as stipulated, may sign the contract.

Contracts, which contain secrecy clauses, may not ordinarily be concluded. The Vice-Chancellor personally must approve any contract containing a secrecy provision,and must submit a full report to the next Senate meeting explaining the circumstances surrounding this (see policy on secret and embargoed research).